Your browser doesn't support javascript.
Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect.
Riggs, Julie M; Charya, Ananth V; Eberlein, Michael H; Reed, Robert M; Saharia, Kapil K.
  • Riggs JM; Program in Transplantation, University of Maryland Medical Center, Baltimore, Maryland, USA. Electronic address: jriggs@umm.edu.
  • Charya AV; Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Eberlein MH; Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Reed RM; Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Saharia KK; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Am J Transplant ; 23(3): 450, 2023 03.
Article in English | MEDLINE | ID: covidwho-2219180

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / Pre-Exposure Prophylaxis Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / Pre-Exposure Prophylaxis Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2023 Document Type: Article